Farlan Veraitch, Co-Founder and Chief Scientific Officer at Ori Biotech has been named as one of the 2021 PM360 ELITE 100

London, UK and Woodcliff Lake, NJ, US, May 14, 2021 PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, has named Farlan Veraitch, Co-Founder and Chief Scientific Officer at Ori Biotech to the 2021 PM360 ELITE 100 in the Entrepreneurship category. Now in its seventh year, the PM360 ELITE (Exceptional • Leaders • Innovators • Transformers • Entrepreneurs) represent the most influential people in the healthcare industry today. 

The PM360 ELITE Awards were established in 2015 to recognize individuals who have made a significant impact on the healthcare industry throughout their careers. More than 500 submissions were received and nominees were evaluated and selected by the PM360 editorial staff based on their accomplishments; testimonials from their bosses, clients, and colleagues; and supporting evidence that reflects the impact of their efforts. A total of 100 winners were selected across 19 categories, including Creative Directors, COVID Heroes, Data Miners, Digital Crusaders, Disrupters, Drug Researchers and Developers, Entrepreneurs, Launch Experts, Leaders of the Future, Marketing Teams, Master Educators, Mentors, Patient Advocates, PR Gurus, Sales MVPs, Strategists, Talent Acquisition Leaders, Tech-know Geeks, and Transformational Leaders.

“As the pandemic surged across the globe in 2020, all eyes were on the healthcare and life sciences industries in search for answers, treatments, vaccines, and hope—and the very best in our industry were able to deliver all of that,” says Anna Stashower, CEO and Publisher of PM360. “While every year our ELITE winners demonstrate the power of the life sciences to impact lives, this year’s winners had to do so by overcoming unprecedented challenges in record times. Their incredible work helped to navigate HCPs, patients, and doctors through this pandemic and get us to where we are now as restrictions are slowly being lifted and we start to return to more of the things we love.”   

The winners were profiled in PM360’s May 2021 issue which you can explore from page 30 for the full article or view Farlan’s winner profile on page 76: https://www.pm360online.com/wp-content/uploads/flipbookjs/live/2105.html.

You can also view Farlan’s profile online at https://www.pm360online.com/elite-2021-entrepreneur-farlan-veraitch-of-ori-biotech/

Additionally, the 2021 ELITE 100 will be celebrated during a virtual event on June 22nd at 7 PM EST. A special keynote address from Uber ELITE Winner Stéphane Bancel, CEO, Moderna will kick-off the celebration.

Tickets for the event can be purchased at https://www.pm360online.com/elitetickets2021.

About PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

About Ori Biotech

Ori is a London and New Jersey based cell and gene therapy (CGT) manufacturing technology company. Ori has developed a proprietary, flexible manufacturing platform that closes, automates and standardizes CGT manufacturing allowing therapeutics developers to further develop and bring their products to market at commercial scale. The promise of the full stack Ori platform is to fully automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining hardware, software and data services.

Ori was founded by Professor Chris Mason (AVRO) and Dr. Farlan Veraitch (UCL) and has brought together a seasoned Board and executive management team with over 100 years of pharmaceutical, CGT and venture building experience including CEO Jason C. Foster (Indivior), CBO Jason Jones (Miltenyi Biotec), VP Tom Heathman (Minaris), VP David Smith (Minaris) alongside expert advisers like Bruce Levine, Anthony Davies and Annalisa Jenkins.

Related Articles

Ori Biotech's Frost & Sullivan 2021 Award
Ori Biotech Press Releases

Ori Biotech receives Frost & Sullivan’s 2021 Global Enabling Technology Leadership Award for cell and gene therapy manufacturing

Read more